This podcast episode provides a professional framework for clinicians navigating the complex and often exaggerated world of regenerative musculoskeletal medicine. The source examines the discrepancy between aggressive marketing and actual scientific evidence for treatments like PRP, stem cell therapy, and newer biologics. It encourages healthcare providers to move beyond being either overly dismissive or baselessly enthusiastic, instead focusing on honest, goal-oriented patient communication. By prioritizing clinical specificity and cost transparency, practitioners can better guide patients toward effective treatments while avoiding regulatory and ethical pitfalls. Ultimately, the text emphasizes that maintaining professional credibility requires ...